Our Commitment to Safety and Transparency as We Study Our Investigational COVID-19 Vaccine Candidate
Learn More
Live Video Series
The Road to a Vaccine
In Season 2 of The Road to a Vaccine, host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.
Season 2 Special
Vaccines 101: Taking a Look at Phase 3 Clinical Trials
Johnson & Johnson’s Dr. Mathai Mammen, Global Head of R&D, discusses how the company’s new global clinical trial phase will work, how safety is a top priority and why the company has chosen to vaccinate up to 60,000 people in Phase 3.
-
What You're Talking About
-
Fact
The first vaccine was introduced in the late 1700s. Can you guess which disease it was developed for?
Recent Johnson & Johnson Initiatives in the Spotlight
Learn more about the company’s latest groundbreaking programs, game-changing innovations and global partnerships—all aimed at helping change the trajectory of health for humanity.
